North American Palladium Ltd. (PAL) Posts Q1 Loss of 1c/Share

North American Palladium Ltd. (NYSE: PAL) reported Q1 EPS of ($0.01), $0.01 worse than the analyst estimate of $0.00. Revenue for the quarter came in at $47.1 million versus the consensus estimate of $43.75 million.

For earnings history and earnings-related data on North American Palladium Ltd. (PAL) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Karyopharm Therapeutics (KPTI) Misses Q2 EPS by $1.01, Beats on Revenue; Offers FY26 Revenue Guidance
• Zenas BioPharma, Inc. (ZBIO) Reports Q2 Loss of $1.77
• Cellectar Biosciences (CLRB) Misses Q2 EPS by 9c